NuProbe Revenue and Competitors

Houston, TX USA

Location

$53M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • NuProbe's estimated annual revenue is currently $4M per year.(i)
  • NuProbe's estimated revenue per employee is $77,500
  • NuProbe's total funding is $53M.

Employee Data

  • NuProbe has 52 Employees.(i)
  • NuProbe grew their employee count by -51% last year.

NuProbe's People

NameTitleEmail/Phone
1
CEO and ChairmanReveal Email/Phone
2
Ex VP, Scientific Research ServiceReveal Email/Phone
3
VP ManufacturingReveal Email/Phone
4
VP R&DReveal Email/Phone
5
Co-Founder and DirectorReveal Email/Phone
6
Associate Director FinanceReveal Email/Phone
7
Associate Director InnovationReveal Email/Phone
8
Director OperationsReveal Email/Phone
9
Senior Laboratory ManagerReveal Email/Phone
10
Scientist IReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.5M1645%N/AN/A
#2
$13.8M89-7%N/AN/A
#3
$18.6M1203%$1.8MN/A
#4
$0.9M6-40%N/AN/A
#5
$4.2M270%N/AN/A
#6
$3.4M2247%N/AN/A
#7
$9.6M6229%N/AN/A
#8
$0.9M620%N/AN/A
#9
$1.7M1110%N/AN/A
#10
$15.2M98-8%N/AN/A
Add Company

What Is NuProbe?

We accelerate technology innovation in precision diagnostics to enable diseases to be detected, treated and cured earlier for better outcomes with lower costs.

keywords:N/A

$53M

Total Funding

52

Number of Employees

$4M

Revenue (est)

-51%

Employee Growth %

N/A

Valuation

N/A

Accelerator

NuProbe News

2022-04-17 - NuProbe Published Method for Designing Highly Multiplex ...

NuProbe is a cutting-edge genomics and molecular diagnostics company with revolutionary molecular diagnostic technologies to improve the...

2022-04-06 - NuProbe QASeq Technology Enables Simultaneous ...

NuProbe is a cutting-edge genomics and molecular diagnostics company with revolutionary molecular diagnostic technologies to improve the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.7M52-7%N/A
#2
$75M520%N/A
#3
$4.8M52-21%N/A
#4
$11.5M5211%N/A
#5
$6.6M5213%N/A